ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Citius Pharmaceuticals Inc

Citius Pharmaceuticals Inc (CTXR)

1.79
0.01
(0.56%)
Closed March 09 3:00PM
1.80
0.01
(0.56%)
After Hours: 6:54PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 003.59M00000
Operating Income -7.25M-10.69M-5.09M-10.13M-9.34M-10.97M-10.63M-11.05M
Pre Tax Income -3.45M-10.38M-8.34M-9.8M-9.09M-8.4M-10.43M-10.93M
Net Income -3.59M-10.24M-8.77M-11.1M-9.23M-8.54M-10.9M-11.52M
Preferred Dividends 000-1.15M0000
Basic Earnings Per Share (EPS) 00000000
EBIT -3.67M-10.69M-5.09M-6.54M-9.34M-10.97M-8.25M-8.66M
EBITDA -7.2M-10.73M-4.94M-10.27M-9.34M-10.97M-10.63M-11.05M
Year End September 29 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -9.99M-13.79M-15.6M-17.71M-23.53M-39.22M-36.73M-42M
Pre Tax Income -10.39M-12.54M-15.56M-17.55M-23.05M-38.97M-31.97M-38.85M
Net Income -10.39M-12.54M-15.56M-17.55M-23.05M-39.54M-33.69M-40.19M
Preferred Dividends 000000-1.15M0
Basic Earnings Per Share (EPS) -2.13-1.502-0.538-0.316-0.158-0.271-0.212-0.222
EBIT -9.99M-12.52M-15.6M-17.6M-23.31M-39.22M-33.15M-39.61M
EBITDA -9.98M-13.79M-15.6M-17.71M-23.53M-39.21M-36.73M-42M

Your Recent History

Delayed Upgrade Clock